ATTD 2024: How do we REALLY use our diabetes devices?

As a former psychosocial health and tech usability researcher, as well as a user of diabetes technology myself, I couldn’t help but be blown away at ATTD 2024 by the insights diabetes tech companies now have into how we actually use their devices, based on their ability to analyse automatic uploads of our data. In this post I'll cover some of the presentations based on automatic uploads, plus other studies that jumped out at me for their psychosocial implications, during the Advanced Technologies and Treatments in Diabetes conference (ATTD 2024).

COVID-19: Today’s diabetes therapy is tomorrow’s outcome data

Reading through the latest COVID-19 diabetes statistics  from the UK/NHS , I'm reminded that I'm in a much stronger position today with my blood glucose levels than I was two years ago. Thanks to DIYAPS. I'm not about to kid myself that I'm invincible - far from it - But it's sobering to realise that if I … Continue reading COVID-19: Today’s diabetes therapy is tomorrow’s outcome data

Ypsomed partners with Dexcom, promises future closed loop using TypeZero algorithm

Medtronic paradigm (522) & Ypsomed Ypsomed and Dexcom have just announced their partnership (4 May 2020) and say a future version of the Ypsomed pump will loop with the TypeZero algorithm, the algorithm used in Tandem's ControlIQ. This partnership is a step forward for a company that says it is committed to patient choice and … Continue reading Ypsomed partners with Dexcom, promises future closed loop using TypeZero algorithm

Ben West – fixing diabetes, changing the conversation

By Mary Anne Patton It’s hard to write about Ben West without “feeling it deep in the heart” as Weston Nordgren put it so well on Twitter. I've been fascinated by Ben ever since I discovered the lengths he went to to liberate diabetes data over a five year period, starting in 2009. Ben's work, Decocare, … Continue reading Ben West – fixing diabetes, changing the conversation